Spring direct naar de hoofdnavigatie of de inhoud

Bart van Wezenbeek

Patent attorney

‘We use our knowledge and experience to optimize your IP position.’
Bart van Wezenbeek

Bart van Wezenbeek

  • Life Sciences
  • European Patent Attorney
  • Dutch Patent Attorney
  • Of counsel

Bart van Wezenbeek started his career in the patent field after he had worked in pharmaceutical research for more than 12 years. He had spent almost three years as a patent information specialist before he switched in 1990 to the patent attorney profession. Since July 2019, Bart has been associated with V.O. as an of-counsel.

Continue reading

From his biology education and pharmaceutical experience, Bart is well suited to deal with inventions in all biological and life science areas, from food and feed applications to deep sequencing and from microbiological diagnostics to gene therapy. Bart has further specific experience in plant related inventions and molecular biological diagnostics.

For many years, Bart headed our patent search and analysis department. Next to his work at V.O. he was involved in the training of trainee patent attorneys and patent information specialists.

Working experience

  • Patent Attorney, V.O. (2002-July 2019)
  • Deputy Justice at the Appeal Court of The Hague (2001-present)
  • Head of the patent department and acting corporate counsel of a small biotech start-up (1995-2002)
  • (Trainee) Patent Attorney in a large pharmaceutical company (1990-1994)
  • Patent Information Specialist in a large pharmaceutical company (1988-1990) Research zoological technician in a large pharmaceutical company (1975-1988)

Education

  • Company counsel, CPO Nijmegen (1997)
  • LLM in Dutch Law, Catholic University Brabant (1994), specializing in intellectual property law
  • Patent information Specialist, Stichting GO, The Hague (1989)
  • MSc in Biology, University of Utrecht (1988), specializing in molecular biology, microbiology and neurobiology

Publications

  • L.A.C.M. van Wezenbeek and T.F.W. Overdijk:  Seaweed and mushrooms on the IP-menu;  travelling along the boundaries for the protection of biological products and inventions. In: Berichten Industriële Eigendom, May/June 2018.
  • The European Patent System. Handbook for the GIIP Offline Campus Learning Module, Global Institute for Intellectual Property, New Delhi, India, 2012.
  • Bart van Wezenbeek. Watch your priorities. In: The Innovation Handbook, Ed. Adam Jolly, 2nd Edition 2010, Kogan Page, London, UK, pages 180-183.
  • G.S.F. Ruigt, J.N. Van Proosdij and L.A.C.M. van Wezenbeek: A large scale, high resolution, automated system for rat sleep staging. II. Validation and application. Electroencephalography and Clinical Neurophysiology 73: 64-71, 1989.
  • L.A.C.M. van Wezenbeek, JA.D.M. Tonnaer and G.S.F.  Ruigt: The endegenous muscarinic acetylcholine receptor in Xenopus oocytes is of the M3 subtype, European Journal of Pharmacology 497-500, 1988.

Professional & Community Activities

  • Contributor to Kluwer Patent Blog
  • Member of the Disciplinary Board of Appeal of the EPO
  • Member of the Disciplinary Council of the Dutch Association of patent attorneys
  • Member of the legal commission of the Dutch Association of patent attorneys
  • Member of the public relations commission of the Dutch Association of patent attorneys
  • Substitute member of the Professional Qualification Commission of the epi
  • Member of FICPI
  • Member of AIPPI
  • Member of WON
  • Member of PIUG
  • Coordinator and tutor of the CEIPI Basic course in The Hague
  • Tutor on the CEIPI Pre-exam training course in Strasbourg
  • Lecturer on the IPKM program, University of Maastricht
  • Trainer on the WON course for Patent Information Specialists, Stichting GO, Voorburg, The Netherlands

Languages

  • English
  • Dutch
  • German

Also see these experts

Marijke Westra

Marijke Westra

  • European Patent Attorney
  • Dutch Patent Attorney
  • Associate
Hajo Kraak

Hajo Kraak

  • European Patent Attorney
  • Dutch Patent Attorney
  • Partner
More experts

News

New on Kluwer Patent Blog: Bayer Intellectual Property GmbH vs. Ceva Santé Animale SA, Nederland

Bayer was not granted an injunction in preliminary proceedings because the Court found that there was a serious chance that Bayer’s patent would be held invalid.Continue reading

New on Kluwer Patent Blog: Recordati Ireland Limited, EPO

A claim defining a compound as having a certain purity would lack novelty over a prior art disclosure describing the same compound only if the prior art disclosed the claimed purity at least implicitly.Continue reading

New on Kluwer Patent Blog: R-Pharm International, LLC, EPO

A request for re-establishment should be filed within two months of the date of removal of non-compliance.Continue reading

Events

Innovation for Health 2020

World Trade Center (WTC) Rotterdam, Beursplein, Rotterdam

Innovation for Health is the premier event for key players in Health & Life Sciences in the Netherlands and Belgium. It provides a unique opportunity to meet leading innovators, to catch up on the latest trends, to present cutting-edge innovations and to engage leaders and decision makers in Life Sciences & Health. Continue reading

2nd LIFE-ON-CHIP Conference 2020

Provincie Vlaams-Brabant - Provinciehuis Leuven, Provincieplein, Leuven, Belgium

Micro- and nanotechnology, artificial intelligence, design thinking, robotics, novel manufacturing technologies and big data have made major impacts across all industries, but perhaps their greatest potential impact will be in health and life sciences. Continue reading

MIP International Patent Forum 2020

etc.venues St Paul's, London, UK

As MIP’s flagship event, over 300 IP counsel register every year, connecting senior patent counsel with their peers from across Europe, Asia and the Americas. Join this event to expand your international business network. Continue reading